Multiple Sclerosis Institute
1 clinical trials · Sponsor
◉ Watch Multiple Sclerosis Institute
| Record | Firm | Date |
|---|---|---|
| A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis (NCT00217295) | Multiple Sclerosis Institute | 2004-04-01 |
Track Multiple Sclerosis Institute automatically
Every clearance here is in the API, with alerts when new ones post.